OracleBio COVID-19 Update
23 March 2020
By Keith Bowers

We would like to assure all our clients that OracleBio are fully set up to deal with any disruptions that may be enforced upon us due to the COVID-19 outbreak. Remote working has been fully established at OracleBio for a number of years and is part of our standard practice. Consequently, we expect there to be no delays in the delivery of study data once we have received your images.

Clients with ongoing or upcoming studies have been contacted by the relevant OracleBio Study Manager. If you have any questions, please do not hesitate to contact us by emailing  or via our website contact form.

Find out more about OracleBio's services

Meet the OracleBio Leadership Team

Stay up to date with OracleBio

Sign up to our mailing list to stay informed about news, webinars, events and more